A newly identified bacterial cell-penetrating peptide that reduces the transcription of pro-inflammatory cytokines

Journal of Cell Science

Volumn 123, Issue 13, 2010, Pages 2190-2198

  Rüter, Christian ^a   Buss, Christoph ^a   Scharnert, Julia ^a   Heusipp, Gerhard ^a   Schmidt, M Alexander ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Cell penetrating peptide; Effector protein; Immunotherapeutic molecule; Pro inflammatory cytokine; YopM

Indexed keywords

BACTERIAL PROTEIN; CELL PENETRATING PEPTIDE; CYTOKINE; UNCLASSIFIED DRUG; YERSINIA OUTER PROTEIN E; YOPM PROTEIN; GREEN FLUORESCENT PROTEIN; HYBRID PROTEIN; OUTER MEMBRANE PROTEIN; TUMOR NECROSIS FACTOR ALPHA; YOPM PROTEIN, YERSINIA;

ALPHA HELIX; AMINO TERMINAL SEQUENCE; ARTICLE; BACTERIAL CELL; CELL TYPE; DOWN REGULATION; HOST CELL; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; CELL MEMBRANE; CHEMISTRY; ENDOPLASMIC RETICULUM; GENETIC TRANSCRIPTION; GENETICS; HELA CELL LINE; HL 60 CELL LINE; IMMUNOLOGY; INFLAMMATION; METABOLISM; PATHOGENICITY; PROTEIN SECONDARY STRUCTURE; YERSINIA ENTEROCOLITICA; YERSINIA PESTIS;

BACTERIAL OUTER MEMBRANE PROTEINS; CYTOKINES; ENDOPLASMIC RETICULUM; GREEN FLUORESCENT PROTEINS; HELA CELLS; HL-60 CELLS; HUMANS; INFLAMMATION; MEMBRANE MICRODOMAINS; PROTEIN STRUCTURE, SECONDARY; RECOMBINANT FUSION PROTEINS; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA; YERSINIA ENTEROCOLITICA; YERSINIA PESTIS;

BACTERIA (MICROORGANISMS); YERSINIA;

EID: 77954355151     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.063016     Document Type: Article

References (51)

1. Anderson, R. G. (1998). The caveolae membrane system. Annu. Rev. Biochem. 67, 199-225.
2. Benabdillah, R., Mota, L. J., Lützelschwab, S., Demoinet, E. and Cornelis, G. R. (2004). Identification of a nuclear targeting signal in YopM from Yersinia spp. Microb. Pathog. 36, 247-261.
3. Bergy, M. E. and Eble, T. E. (1968). The filipin complex. Biochemistry 7, 653-659.
4. Conner, S. D. and Schmid, S. L. (2003). Regulated portals of entry into the cell. Nature 422, 37-44.
5. Cornelis, G. R. (2002). The Yersinia Ysc-Yop 'type III' weaponry. Nat. Rev. Mol. Cell Biol. 3, 742-752.
6. Dai, S., Hirayama, T., Abbas, S. and Abu-Amer, Y. (2004). The IkappaB kinase (IKK) inhibitor, NEMO-binding domain peptide, blocks osteoclastogenesis and bone erosion in inflammatory arthritis. J. Biol. Chem. 279, 37219-37222.
7. Dietz, G. P. and Bahr, M. (2004). Delivery of bioactive molecules into the cell: the Trojan horse approach. Mol. Cell. Neurosci. 27, 85-131.
8. Drin, G., Cottin, S., Blanc, E., Rees, A. R. and Temsamani, J. (2003). Studies on the internalization mechanism of cationic cell-penetrating peptides. J. Biol. Chem. 278, 31192-31201.
9. el Bayâ, A., Linnemann, R., von Olleschik-Elbheim, L., Robenek, H. and Schmidt, M. A. (1997). Endocytosis and retrograde transport of pertussis toxin to the Golgi complex as a prerequisite for cellular intoxication. Eur. J. Cell Biol. 73, 40-48.
10. Evdokimov, A. G., Anderson, D. E., Routzahn, K. M. and Waugh, D. S. (2000). Overproduction, purification, crystallization and preliminary X-ray diffraction analysis of YopM, an essential virulence factor extruded by the plague bacterium Yersinia pestis. Acta Crystallogr. D Biol. Crystallogr. 56, 1676-1679.
11. Fischer, R., Fotin-Mleczek, M., Hufnagel, H. and Brock, R. (2005). Break on through to the other side-biophysics and cell biology shed light on cell-penetrating peptides. Chembiochem. 6, 2126-2142.
12. Foerg, C., Ziegler, U., Fernandez-Carneado, J., Giralt, E., Rennert, R., Beck-Sickinger, A. G. and Merkle, H. P. (2005). Decoding the entry of two novel cell-penetrating peptides in HeLa cells: lipid raft-mediated endocytosis and endosomal escape. Biochemistry 44, 72-81.
13. Fotin-Mleczek, M., Fischer, R. and Brock, R. (2005a). Endocytosis and cationic cell-penetrating peptides-a merger of concepts and methods. Curr. Pharm. Des. 11, 3613-3628.
14. Fotin-Mleczek, M., Welte, S., Mader, O., Duchardt, F., Fischer, R., Hufnagel, H., Scheurich, P. and Brock, R. (2005b). Cationic cell-penetrating peptides interfere with TNF signalling by induction of TNF receptor internalization. J. Cell. Sci. 118, 3339-3351.
15. Frankel, A. D. and Pabo, C. O. (1988). Cellular uptake of the tat protein from human immunodeficiency virus. Cell 55, 1189-1193.
16. Green, M. and Loewenstein, P. M. (1988). Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein. Cell 55, 1179-1188.
17. Hanzal-Bayer, M. F. and Hancock, J. F. (2007). Lipid rafts and membrane traffic. FEBS Lett. 581, 2098-2104.
18. Haraga, A. and Miller, S. I. (2003). A Salmonella enterica serovar typhimurium translocated leucine-rich repeat effector protein inhibits NF-κB-dependent gene expression. Infect. Immun. 71, 4052-4058.
19. Heusipp, G., Spekker, K., Brast, S., Fälker, S. and Schmidt, M. A. (2006). YopM of Yersinia enterocolitica specifically interacts with α1-antitrypsin without affecting the anti-protease activity. Microbiology 152, 1327-1335.
20. Hines, J., Skrzypek, E., Kajava, A. V. and Straley, S. C. (2001). Structure-function analysis of Yersinia pestis YopM's interaction with alpha-thrombin to rule on its significance in systemic plague and to model YopM's mechanism of binding host proteins. Microb. Pathog. 30, 193-209.
21. Jimi, E., Aoki, K., Saito, H., D'Acquisto, F., May, M. J., Nakamura, I., Sudo, T., Kojima, T., Okamoto, F., Fukushima, H. et al. (2004). Selective inhibition of NF-κB blocks osteoclastogenesis and prevents inflammatory bone destruction in vivo. Nat. Med. 10, 617-624.
22. Johannes, L. and Goud, B. (2000). Facing inward from compartment shores: how many pathways were we looking for? Traffic 1, 119-123.
23. Kenny, B. and Finlay, B. B. (1997). Intimin-dependent binding of enteropathogenic Escherichia coli to host cells triggers novel signaling events, including tyrosine phosphorylation of phospholipase C-gamma1. Infect. Immun. 65, 2528-2536.
24. Kerschen, E. J., Cohen, D. A., Kaplan, A. M. and Straley, S. C. (2004). The plague virulence protein YopM targets the innate immune response by causing a global depletion of NK cells. Infect. Immun. 72, 4589-4602.
25. Kobe, B. and Kajava, A. V. (2001). The leucine-rich repeat as a protein recognition motif. Curr. Opin. Struct. Biol. 11, 725-732.
26. Koch, A. M., Reynolds, F., Kircher, M. F., Merkle, H. P., Weissleder, R. and Josephson, L. (2003). Uptake and metabolism of a dual fluorochrome Tat-nanoparticle in HeLa cells. Bioconjug. Chem. 14, 1115-1121.
27. Langel, U. (2005). Handbook of cell-penetrating peptides. Boca Raton: CRC Press, Taylor and Francis Group.
28. Le Buanec, H., Delavallee, L., Bessis, N., Paturance, S., Bizzini, B., Gallo, R., Zagury, D. and Boissier, M. C. (2006). TNFα kinoid vaccination-induced neutralizing antibodies to TNFα protect mice from autologous TNFα-driven chronic and acute inflammation. Proc. Natl. Acad. Sci. USA 103, 19442-19447.
29. Lencer, W. I. and Tsai, B. (2003). The intracellular voyage of cholera toxin: going retro. Trends Biochem. Sci. 28, 639-645.
30. Lundberg, M., Wikstrom, S. and Johansson, M. (2003). Cell surface adherence and endocytosis of protein transduction domains. Mol. Ther. 8, 143-150.
31. Macia, E., Ehrlich, M., Massol, R., Boucrot, E., Brunner, C. and Kirchhausen, T. (2006). Dynasore, a cell-permeable inhibitor of dynamin. Dev. Cell 10, 839-850.
32. Magzoub, M., Oglecka, K., Pramanik, A., Göran Eriksson, L. E. and Gräslund, A. (2005). Membrane perturbation effects of peptides derived from the N-termini of unprocessed prion proteins. Biochim. Biophys. Acta. 1716, 26-36.
33. Maiolo, J. R., Ferrer, M. and Ottinger, E. A. (2005). Effects of cargo molecules on the cellular uptake of arginine-rich cell-penetrating peptides. Biochim. Biophys. Acta 1712, 161-172.
34. May, M. J., D'Acquisto, F., Madge, L. A., Glöckner, J., Pober, J. S. and Ghosh, S. (2000). Selective inhibition of NF-κB activation by a peptide that blocks the interaction of NEMO with the IκB kinase complex. Science 289, 1550-1554.
35. McDonald, C., Vacratsis, P. O., Bliska, J. B. and Dixon, J. E. (2003). The Yersinia virulence factor YopM forms a novel protein complex with two cellular kinases. J. Biol. Chem. 278, 18514-18523.
36. Medina-Kauwe, L. K. (2007). 'Alternative' endocytic mechanisms exploited by pathogens: new avenues for therapeutic delivery? Adv. Drug Deliv. Rev. 59, 798-809.
37. Mi, Z., Lu, X., Mai, J. C., Ng, B. G., Wang, G., Lechman, E. R., Watkins, S. C., Rabinowich, H. and Robbins, P. D. (2003). Identification of a synovial fibroblast-specific protein transduction domain for delivery of apoptotic agents to hyperplastic synovium. Mol. Ther. 8, 295-305.
38. Michgehl, S., Heusipp, G., Greune, L., Rüter, C. and Schmidt, M. A. (2006). Espindependent functional integration of the translocated intimin receptor (Tir) of enteropathogenic Escherichia coli (EPEC) into host cell membranes. Cell. Microbiol. 8, 625-633.
39. Mitchell, D. J., Kim, D. T., Steinman, L., Fathman, C. G. and Rothbard, J. B. (2000). Polyarginine enters cells more efficiently than other polycationic homopolymers. J. Pept. Res. 56, 318-325.
40. Potocky, T. B., Menon, A. K. and Gellman, S. H. (2003). Cytoplasmic and nuclear delivery of a TAT-derived peptide and a beta-peptide after endocytic uptake into HeLa cells. J. Biol. Chem. 278, 50188-50194.
41. Richard, J. P., Melikov, K., Vives, E., Ramos, C., Verbeure, B., Gait, M. J., Chernomordik, L. V. and Lebleu, B. (2003). Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake. J. Biol. Chem. 278, 585-590.
42. Rohde, J. R., Breitkreutz, A., Chenal, A., Sansonetti, P. J. and Parsot, C. (2007). Type III secretion effectors of the IpaH family are E3 ubiquitin ligases. Cell Host Microbe 1, 77-83.
43. Sandvig, K. and van Deurs, B. (2005). Delivery into cells: lessons learned from plant and bacterial toxins. Gene Ther. 12, 865-872.
44. Schmid, S. L. (1997). Clathrin-coated vesicle formation and protein sorting: an integrated process. Annu. Rev. Biochem. 66, 511-548.
45. Shogomori, H. and Futerman, A. H. (2001). Cholesterol depletion by methyl-beta-cyclodextrin blocks cholera toxin transport from endosomes to the Golgi apparatus in hippocampal neurons. J. Neurochem. 78, 991-999.
46. Skrzypek, E., Cowan, C. and Straley, S. C. (1998). Targeting of the Yersinia pestis YopM protein into HeLa cells and intracellular trafficking to the nucleus. Mol. Microbiol. 30, 1051-1065.
47. Skrzypek, E., Myers-Morales, T., Whiteheart, S. W. and Straley, S. C. (2003). Application of a Saccharomyces cerevisiae model to study requirements for trafficking of Yersinia pestis YopM in eucaryotic cells. Infect. Immun. 71, 937-947.
48. Thoren, P. E., Persson, D., Isakson, P., Goksor, M., Onfelt, A. and Norden, B. (2003). Uptake of analogs of penetratin, Tat(48-60) and oligoarginine in live cells. Biochem. Biophys. Res. Commun. 307, 100-107.
49. Vendeville, A., Rayne, F., Bonhoure, A., Bettache, N., Montcourrier, P. and Beaumelle, B. (2004). HIV-1 Tat enters T cells using coated pits before translocating from acidified endosomes and eliciting biological responses. Mol. Biol. Cell 15, 2347-2360.
50. Weckmann, A. L. and Alcocer-Varela, J. (1996). Cytokine inhibitors in autoimmune disease. Semin. Arthritis Rheum. 26, 539-557.
51. Zhu, Y., Li, H., Hu, L., Wang, J., Zhou, Y., Pang, Z., Liu, L. and Shao, F. (2008). Structure of a Shigella effector reveals a new class of ubiquitin ligases. Nat. Struct. Mol. Biol. 15, 1302-1308.